1Fountzilas G,Ciuleanu E,Dafni U,et al.Concomitant radi-ochemotherapy vs radiotherapy alone in patients with head and neck cancer:a Hellenic Cooperative Oncology Group Phase Ⅲ Study[J].Med Oncol,2004,21(2):95.
2Forastiere AA,Goepfert H,Maor M,et al.Concurrent che-motherapy and radiotherapy for organ preservation in advanced laryngeal cancer[J].N Engl J Med,2003,349(22):2091.
3Lau H,Brar S,Hao D,MacKinnon J,et al.Concomitant low-dose cisplatin and three-dimensional conformal radiotherapy for locally advanced squamous cell carcinoma of the head and neck:Analysis of survival and toxicity[J].Head Neck,2006,28(3):189.
4Herbst RS,Arquette M,Shin DM,et al.Phase Ⅱ multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck[J].J Clin Oncol,2005,23:5578.
5Burtness B,Goldwasser MA,Flood W,et al.Phase Ⅲ randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer:An Eastern Cooperative Oncology Group Study[J].J Clin Oncol,2005,23:8646.
6Bonner JA,Harari PM,Giralt J,et al.Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck[J].N Engl J Med,2006,354(6):567.
7Trigo J,Hitt R,Koralewski P,etal.Cetuximab monotherapy is active in patients (pts) with platinum-refractory recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN):results of a Phase Ⅱ study[J].Proc Am Soc Clin Oncol,2004,23:5502.
8Wheeler RH,Jones D,Sharma P,etal.Clinical and molecular Phase Ⅱ study of ge?tinib in patients (pts) with recurrent squamous cell cancer of the head and neck[J].Proc Am Soc Clin Oncol,2005,23:5531.
9Belon J,Irigoyen A,Rodriguez I,et al.Preliminary results of a Phase Ⅱ study to evaluate ge?tinib combined with docetaxel and cisplatin in patients with recurrent and/or metastatic squamous-cell carcinoma of the head and neck[J].Proc Am Soc Clin Oncol,2005,23:5563
10Cohen EEW,Haraf DJ,Stenson KM,et al.Integration of ge?tinib (G),into a concurrent chemoradiation (CRT) regimen followed by G adjuvant therapy in patients with locally advanced head and neck cancer (HNC)-a Phase Ⅱ trial[J].Proc Am Soc Clin Oncol,2005,23:5506.
